Milford

MILFORD, Massachusetts, November 10, 2010 - Waters Corporation (NYSE: WAT) today welcomed into its Centers of Innovation Program the Drug Control Centre within the Department of Forensic Science and Drug Monitoring at King's College London.

MILFORD, Massachusetts - Centerpiece of the is the establishment of The Waters Centre for BioMedical Mass Spectrometry Waters Corporation (NYSE: WAT) and the University of Warwick, Coventry and Warwickshire, England, today signed a collaborative research agreement intended to support the growth, development and adoption of novel mass spectrometry (MS) technologies, including Waters(R) SYNAPT High Definition MS(TM) (HDMS(TM)) system.